Strategy for managing patients with severe cases of rosacea
- 作者: Sergeyeva I.G.1, Krinitsyna Y.M.2
 - 
							隶属关系: 
							
- Novosibirsk State National Research University
 - Research Institute of regional Pathology and Pathomorphology
 
 - 期: 卷 92, 编号 5 (2016)
 - 页面: 72-78
 - 栏目: DRUG TREATMENT IN DERMATOVENEROLOGY
 - URL: https://bakhtiniada.ru/0042-4609/article/view/116834
 - DOI: https://doi.org/10.25208/0042-4609-2016-92-5-72-78
 - ID: 116834
 
如何引用文章
全文:
详细
作者简介
I. Sergeyeva
Novosibirsk State National Research University
							编辑信件的主要联系方式.
							Email: i_g_sergeeva@mail.ru
				                					                																			                												                	俄罗斯联邦													
Yu. Krinitsyna
Research Institute of regional Pathology and Pathomorphology
														Email: noemail@neicon.ru
				                					                																			                												                	俄罗斯联邦													
参考
- Araviyskaya E.R.. Samtsov A.V. Federalnyye klinicheskiye rekomendatsii po vedeniyu bolnykh rozatsea. Moskva; 2015
 - Rademaker M. Very low-dose isotretinoin in mild to moderate papulopustular rosacea; a retrospective review of 52 patients. The Australasian Journal Of Dermatology 2016; 20: 1440-0960.
 - Sbidian E., Vicaut É., Chosidow O. et al. A Randomized-Controlled Trial of Oral Low-Dose Isotretinoin for Difficult-To-Treat Papulopustular Rosacea. The Journal Of Investigative Dermatology 2016; 136 (6): 1124-1129.
 - Millikan L. The proposed inflammatory pathophysiology of rosacea: implications for treatment. Skinmed 2003; 2: 43-47.
 - Egeberg A., Hansen P., Gislason G., Thyssen J. Patients with Rosacea Have Increased Risk of Depression and Anxiety Disorders: A Danish Nationwide Cohort Study. Dermatology 2016; 232 (2): 208-213.
 - Monakhov S.A. Rozatsea (metodicheskoye posobiye dlya vrachey). M; 2016.
 - Samtsov A.V. Gorbunov Yu.G. Izotretinoin v lechenii rozatsea. Vestn dermatol venerol 2012; (4): 102-104
 
补充文件
				
			
						
						
					
				

